Oxford and AstraZeneca's vaccine won't just go to rich countries
Posted on AllSides November 23rd, 2020
From The Left
![](https://dev.allsides.com/sites/default/files/styles/news_large_image/public/1606154472050.jpg?itok=wpSHLdbK)
ANALYSIS
While the 95% efficacy rates for the Moderna and Pfizer/BioNTech vaccines are great news for the U.S. and Europe, Monday's announcement from Oxford and AstraZeneca may be far more significant for the rest of the world.
Why it matters: Oxford and AstraZeneca plan to distribute their vaccine at cost (around $3-4 per dose), and have already committed to providing over 1 billion doses to the developing world. The price tags are higher for the Pfizer ($20) and Moderna ($32-37) vaccines.
Details: The Oxford/AstraZeneca vaccine had an average efficacy of 70%...